We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
scPharmaceuticals Inc | NASDAQ:SCPH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.66 | 4.45 | 4.95 | 4.85 | 4.54 | 4.76 | 159,989 | 05:00:08 |
Jefferies 2019 Global Healthcare ConferencePresentation: Friday, June 7, 2019 at 8:30 AM EDTLocation: Grand Hyatt, New York, NY
BMO’s 2019 Prescriptions for Success Healthcare ConferencePresentation: Tuesday, June 25, 2019 at 3:20 PM EDTLocation: Mandarin Oriental, New York, NY
About scPharmaceuticals scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, products for the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit scPharmaceuticals.com.
Contacts:Katherine Taudvin, scPharmaceuticals Inc.781-301-6706ktaudvin@scpharma.com
Christopher F. Brinzey, Westwicke an ICR Company339-970-2843chris.brinzey@westwicke.com
1 Year scPharmaceuticals Chart |
1 Month scPharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions